Treatment of pulmonary arterial hypertension

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61P 9/12 (2006.01)

Patent

CA 2732789

The present invention pertains to the use of 4-(4-methylpiperazin-1-ylmethyl)- N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutically acceptable salt thereof or a pyrimidylaminobenzamide of formula I wherein the radicals and symbols are as defined herein, or a pharmaceutically acceptable salt thereof, for the manufacture of medicament for treating pulmonary arterial hypertension (PAH), especially in patients who failed prior PAH therapy.

La présente invention concerne lutilisation du 4-(4-méthylpipérazin-1-yl-méthyl)-N-[4-méthyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phényl]-benzamide ou de lun de ses sels pharmaceutiquement acceptables ou dun pyrimidylaminobenzamide de formule I dans laquelle les radicaux et les symboles sont tels que définis dans ce document, ou de lun de ses sels pharmaceutiquement acceptables, pour la fabrication dun médicament destiné au traitement de lhypertension artérielle pulmonaire (HAP), spécialement chez les patients pour lesquels un traitement antérieur de la HAP a échoué.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of pulmonary arterial hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of pulmonary arterial hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of pulmonary arterial hypertension will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1444352

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.